Aclidinium Bromide (Standard)
Aclidinium (Bromide) (Standard) is the analytical standard of Aclidinium (Bromide). This product is intended for research and analytical applications. Aclidinium Bromide (LAS 34273; LAS-W 330) is a long-acting, inhaled muscarinic antagonist. Aclidinium Bromide has the potential for chronic obstructive pulmonary disease (COPD) research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 98%
- CAS No.: 320345-99-1
- Formule: C26H30BrNO4S2
- Masse moléculaire:564.55
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-14144
Aclidinium Bromide
-
HY-12100
Umeclidinium bromide
-
HY-A0030
Fesoterodine fumarate
-
HY-90010
Tolterodine tartrate
-
HY-70020
Cevimeline
-
HY-17037
Pirenzepine dihydrochloride
-
HY-101381
Otenzepad
-
HY-13204
Biperiden hydrochloride
-
HY-A0012
Darifenacin hydrobromide
-
HY-A0002
Solifenacin Succinate
-
HY-B1277
Trihexyphenidyl hydrochloride
-
HY-12157
VU 0238429
Product Information
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 320345-99-1
-
Masse moléculaire 564.55
-
Formule C26H30BrNO4S2
-
SMILES
O=C(O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)C(C4=CC=CS4)(O)C5=CC=CS5.[Br-]
-
Synonyms
LAS 34273 (Standard); LAS-W 330 (Standard)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Cazzola M. Aclidinium bromide, a novel long-acting muscarinic M3 antagonist for the treatment of COPD. Curr Opin Investig Drugs. 2009 May;10(5):482-90. [Content Brief]
[2]. Joos GF. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease. Expert Opin Investig Drugs. 2010 Feb;19(2):257-64. [Content Brief]
[3]. Sentellas S, Ramos I, Albertí J et al. Aclidinium bromide, a new, long-acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolites. Eur J Pharm Sci. 2010 Mar 18;39(5):283-90. [Content Brief]
[4]. Sims MW, Panettieri RA Jr. Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:457-66. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Aclidinium Bromide (Standard) Related Classifications
HY-14144R Related Classifications
Powered by Bioz